Literature DB >> 25243263

Global programme to eliminate lymphatic filariasis: progress report, 2013.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25243263

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  16 in total

1.  Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.

Authors:  Jennifer S F da Silva; Cynthia Braga; Felipe M Duarte; Paula Oliveira; Carlos Feitosa Luna; Márcia Marcondes; Josué Araújo; Maria Rosangela Grilis; Paula Fernanda A de Souza Melo; Eduardo Brandão; Abraham Rocha
Journal:  Pathog Glob Health       Date:  2018-08-15       Impact factor: 2.894

2.  Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.

Authors:  Tekola Endeshaw; Aseged Taye; Zerihun Tadesse; Moses N Katabarwa; Oumer Shafi; Tewodros Seid; Frank O Richards
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

3.  Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination program.

Authors:  Rita M Dewi; Sekar Tuti; Sitti Ganefa; Chairiyah Anwar; Ria Larasati; Endah Ariyanti; Herty Herjati; Molly Brady
Journal:  Parasit Vectors       Date:  2015-10-01       Impact factor: 3.876

4.  A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration.

Authors:  Thishan C Yahathugoda; Taniawati Supali; Ramakrishna U Rao; Yenny Djuardi; Difa Stefani; Femmy Pical; Peter U Fischer; Melanie M Lloyd; Prasad H Premaratne; Mirani V Weerasooriya; Gary J Weil
Journal:  Parasit Vectors       Date:  2015-07-15       Impact factor: 3.876

5.  Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination.

Authors:  Neal D E Alexander
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01-08       Impact factor: 2.184

6.  Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.

Authors:  Yaya I Coulibaly; Siaka Y Coulibaly; Housseini Dolo; Siaka Konate; Abdallah A Diallo; Salif S Doumbia; Lamine Soumaoro; Michel E Coulibaly; Ilo Dicko; Moussa B Sangare; Benoit Dembele; Modibo Sangare; Massitan Dembele; Yeya T Touré; Louise Kelly-Hope; Katja Polman; Dominique Kyelem; Sekou F Traore; Moses Bockarie; Amy D Klion; Thomas B Nutman
Journal:  Parasit Vectors       Date:  2016-12-03       Impact factor: 3.876

7.  Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis.

Authors:  Molly A Brady; Rachel Stelmach; Margaret Davide-Smith; Jim Johnson; Bolivar Pou; Joseph Koroma; Kingsley Frimpong; Angela Weaver
Journal:  PLoS Negl Trop Dis       Date:  2017-02-01

8.  Blue Marble Health Redux: Neglected Tropical Diseases and Human Development in the Group of 20 (G20) Nations and Nigeria.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2015-07-28

9.  Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.

Authors:  Paula Moraga; Jorge Cano; Rebecca F Baggaley; John O Gyapong; Sammy M Njenga; Birgit Nikolay; Emmanuel Davies; Maria P Rebollo; Rachel L Pullan; Moses J Bockarie; T Déirdre Hollingsworth; Manoj Gambhir; Simon J Brooker
Journal:  Parasit Vectors       Date:  2015-10-24       Impact factor: 3.876

10.  Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Authors:  Eileen Stillwaggon; Larry Sawers; Jonathan Rout; David Addiss; LeAnne Fox
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.